Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study.
about
Immune thrombocytopeniaThromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.Thrombotic complications after intravenous immunoglobulin therapy in two patients.Lupus anticoagulant in immune thrombocytopenic purpura.Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission.Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis.Suspects in the tale of lupus-associated thrombocytopenia.Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients.Antiphospholipid antibodies in adults with immune thrombocytopenic purpura.Pathobiology of secondary immune thrombocytopenia.Primary antiphospholipid syndrome and Evan's syndrome: 2 case reports.Thrombocytopenias: a clinical point of view.Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research DatabaseTask Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations.Immune thrombocytopenia with antiphospholipid antibodies in monozygotic twins.Clinical implications of elevated antiphospholipid antibodies in adult patients with primary immune thrombocytopeniaManagement of myocardial infarction in immune thrombocytopenic purpura with anti-phospholipid antibodies.Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases.Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies.Contemporary treatment of immune thrombocytopenia.Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.A Seeming Paradox: Ischemic Stroke in the Context of Idiopathic Thrombocytopenic Purpura.The challenge of bleeding in antiphospholipid antibody-positive patients.The significance and management of thrombocytopenia in antiphospholipid syndrome.Current treatment of antiphospholipid syndrome: lights and shadows.Is ITP a thrombophilic disorder?Right Atrial Thrombosis in Antiphospholipid Syndrome with Secondary Immune Thrombocytopenia.Refractory Immunological Thrombocytopenia Purpura and Splenectomy in Pregnancy.Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian Population.Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies.Achieving a satisfactory clinical and biochemical response in antiphospholipid syndrome and severe thrombocytopenia with rituximab: two case reportsThrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis.Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis.The antiphospholipid syndrome: from pathophysiology to treatment.Splenectomy for Immune Thrombocytopenia: Down but not out.Management of immune thrombocytopenia: Korean experts recommendation in 2017.
P2860
Q26830918-6935A5A1-9E09-4DC5-963D-A6A7AC3F8406Q30250259-DE461A6A-5AF4-436C-B71C-49393D92AD2AQ33345805-72D851E1-89E7-41A8-A1B3-18C7DA28446FQ33361494-7B7227BE-9F59-48C2-AE2C-9C9CFB3A6EDFQ33364647-8D50B69C-731D-491E-B34C-5EEF1572B467Q33368167-A831AF5E-A283-466D-8C1B-C9AD9A3FBE46Q33371650-6D2FA74E-0DE2-43EF-A0D8-FE3FCB5B3798Q33377847-0F3CD0BB-9124-48BE-9717-DFB5FE429587Q33379770-B33C414B-FC45-4E01-B3E4-44310C645A0AQ33383468-FEEE927F-EFAD-4552-8BFC-D7A37E839CC4Q33383854-1534F86F-3142-498A-B64C-F005BC9952D2Q33384884-752E421E-F555-42F8-BF82-3B1384382130Q33388213-CCC03467-A046-45D7-947D-BA3C935F04B5Q33394044-1E6191D8-AB2C-4BF2-BCA3-3E849BA97B99Q33397398-EF6E803B-0629-45B0-9F81-BC4A64ADEDA5Q33398955-5ACB0CB3-1D63-4C3F-AF68-7D75656C247FQ33401971-467AB2BF-6C7B-4F34-8D42-9CDB963C5F61Q33405669-95B59834-AFBE-4F21-AA9E-2F1A74F5E9B4Q33406643-5F004FC9-74A0-487A-8CA6-21A601094453Q33410653-3FD75276-98CD-424A-BBF3-FF4B07832D40Q33415996-AA842EFF-CA87-4E6F-8646-0BF9CC746F88Q33417001-9D1F3FD0-8ACA-468E-A4EB-47BC1E4722D5Q33419972-BB020452-2EEC-4F85-B299-9DFCC6283148Q33420910-E099EE6C-56E8-4100-AF6C-CA56BF11F3FBQ33423959-00964A06-826F-4FED-BA1B-DC78162FC744Q33427394-D752AB00-C852-47E2-81C6-F3FB81E53728Q33428599-967D03DF-7715-4BD6-95CD-CD86B6EDDA1FQ33429418-8372702C-D69D-462C-9B31-6E485E79DFD6Q33431417-8F472718-26EA-4903-BA4D-CCE02DE17E31Q33431551-8E06386A-A157-4C5C-8C17-2F114C9EFBCEQ33442480-57DE2F37-0FC8-4E35-8C13-E5AD1F737E75Q33443108-D4474960-B85C-4680-B819-AB1F682570B6Q35189289-C3991D6C-EE4A-492F-B26E-4E195A5754AAQ36915667-67135F2E-4DEB-4753-8B3D-71BE8A243642Q38856073-2435A91C-6ACD-420A-8D28-604A5F4EAFE5Q38873953-ED8900DF-30A9-4C9B-AAA3-BE61C78D0D44Q47754303-225E29FA-3B25-4183-9DC4-28D9CC5D88E6Q49624514-BC769742-B4F6-4F65-B060-BB898286C69F
P2860
Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antiphospholipid antibodies an ...... a: a prospective cohort study.
@ast
Antiphospholipid antibodies an ...... a: a prospective cohort study.
@en
Antiphospholipid antibodies an ...... a: a prospective cohort study.
@nl
type
label
Antiphospholipid antibodies an ...... a: a prospective cohort study.
@ast
Antiphospholipid antibodies an ...... a: a prospective cohort study.
@en
Antiphospholipid antibodies an ...... a: a prospective cohort study.
@nl
prefLabel
Antiphospholipid antibodies an ...... a: a prospective cohort study.
@ast
Antiphospholipid antibodies an ...... a: a prospective cohort study.
@en
Antiphospholipid antibodies an ...... a: a prospective cohort study.
@nl
P2093
P921
P356
P1433
P1476
Antiphospholipid antibodies an ...... a: a prospective cohort study.
@en
P2093
Diz-Küçükkaya R
Hacihanefioğlu A
P304
P356
10.1182/BLOOD.V98.6.1760
P407
P577
2001-09-01T00:00:00Z